S&P 500   4,560.65 (+0.35%)
DOW   35,740.74 (+0.18%)
QQQ   376.08 (+0.53%)
AAPL   148.28 (-0.28%)
MSFT   307.96 (-0.39%)
FB   323.95 (-0.20%)
GOOGL   2,739.57 (-0.43%)
TSLA   972.31 (+6.88%)
AMZN   3,303.72 (-0.95%)
NVDA   230.59 (+1.47%)
BABA   175.17 (-1.42%)
NIO   40.66 (+4.58%)
CGC   13.28 (-0.75%)
GE   105.58 (+1.47%)
AMD   121.53 (+1.43%)
MU   68.78 (+1.88%)
T   25.43 (-0.24%)
F   16.12 (-0.98%)
ACB   7.11 (+0.57%)
DIS   170.55 (+0.67%)
PFE   42.85 (-0.72%)
BA   212.41 (-0.26%)
AMC   37.67 (+2.92%)
S&P 500   4,560.65 (+0.35%)
DOW   35,740.74 (+0.18%)
QQQ   376.08 (+0.53%)
AAPL   148.28 (-0.28%)
MSFT   307.96 (-0.39%)
FB   323.95 (-0.20%)
GOOGL   2,739.57 (-0.43%)
TSLA   972.31 (+6.88%)
AMZN   3,303.72 (-0.95%)
NVDA   230.59 (+1.47%)
BABA   175.17 (-1.42%)
NIO   40.66 (+4.58%)
CGC   13.28 (-0.75%)
GE   105.58 (+1.47%)
AMD   121.53 (+1.43%)
MU   68.78 (+1.88%)
T   25.43 (-0.24%)
F   16.12 (-0.98%)
ACB   7.11 (+0.57%)
DIS   170.55 (+0.67%)
PFE   42.85 (-0.72%)
BA   212.41 (-0.26%)
AMC   37.67 (+2.92%)
S&P 500   4,560.65 (+0.35%)
DOW   35,740.74 (+0.18%)
QQQ   376.08 (+0.53%)
AAPL   148.28 (-0.28%)
MSFT   307.96 (-0.39%)
FB   323.95 (-0.20%)
GOOGL   2,739.57 (-0.43%)
TSLA   972.31 (+6.88%)
AMZN   3,303.72 (-0.95%)
NVDA   230.59 (+1.47%)
BABA   175.17 (-1.42%)
NIO   40.66 (+4.58%)
CGC   13.28 (-0.75%)
GE   105.58 (+1.47%)
AMD   121.53 (+1.43%)
MU   68.78 (+1.88%)
T   25.43 (-0.24%)
F   16.12 (-0.98%)
ACB   7.11 (+0.57%)
DIS   170.55 (+0.67%)
PFE   42.85 (-0.72%)
BA   212.41 (-0.26%)
AMC   37.67 (+2.92%)
S&P 500   4,560.65 (+0.35%)
DOW   35,740.74 (+0.18%)
QQQ   376.08 (+0.53%)
AAPL   148.28 (-0.28%)
MSFT   307.96 (-0.39%)
FB   323.95 (-0.20%)
GOOGL   2,739.57 (-0.43%)
TSLA   972.31 (+6.88%)
AMZN   3,303.72 (-0.95%)
NVDA   230.59 (+1.47%)
BABA   175.17 (-1.42%)
NIO   40.66 (+4.58%)
CGC   13.28 (-0.75%)
GE   105.58 (+1.47%)
AMD   121.53 (+1.43%)
MU   68.78 (+1.88%)
T   25.43 (-0.24%)
F   16.12 (-0.98%)
ACB   7.11 (+0.57%)
DIS   170.55 (+0.67%)
PFE   42.85 (-0.72%)
BA   212.41 (-0.26%)
AMC   37.67 (+2.92%)
NASDAQ:PRTC

PureTech Health Short Interest Ratio and Short Volume

$47.60
-3.40 (-6.67 %)
(As of 10/22/2021 12:00 AM ET)
Add
Compare
Today's Range
$47.50
$48.28
50-Day Range
$44.48
$53.44
52-Week Range
$33.00
$65.90
Volume281 shs
Average Volume2,543 shs
Market Capitalization$1.36 billion
P/E Ratio2,380.00
Dividend YieldN/A
BetaN/A

PureTech Health (NASDAQ:PRTC) Short Interest Data

Current Short Volume7,800 shares
Previous Short Volume100 shares
Change Vs. Previous Month+7,700.00%
Dollar Volume Sold Short$374,322.00
Short Interest Ratio / Days to Cover2.5
Last Record DateSeptember, 30 2021
Outstanding Shares28,655,000 shares
Percentage of Shares Shorted0.03%
Today's Trading Volume281 shares
Average Trading Volume2,543 shares
Today's Volume Vs. Average-88.95%

Days to Cover Over Time

Percentage of Float Shorted Over Time

cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling PureTech Health ?

Sign up to receive the latest short interest report for PureTech Health and its competitors with MarketBeat's FREE newsletter.

PureTech Health (NASDAQ:PRTC) Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
9/30/20217,800 shares $374,322.00 +7,700.0%N/A2.5 $47.99
9/15/2021100 shares $4,950.00 -92.9%N/A0 $49.50
8/31/20211,400 shares $70,000.00 -75.4%N/A0.9 $50.00
8/13/20215,700 shares $253,536.00 -38.0%N/A8.1 $44.48
7/30/20219,200 shares $438,748.00 +1.1%N/A23 $47.69
7/15/20219,100 shares $393,120.00 +19.7%N/A22.8 $43.20
6/30/20217,600 shares $372,400.00 No ChangeN/A25.3 $49.00
6/15/20217,600 shares $438,976.00 +230.4%N/A19 $57.76
5/28/20212,300 shares $128,478.00 +21.1%N/A5.8 $55.86
5/14/20211,900 shares $98,895.00 +46.2%N/A9.5 $52.05
4/30/20211,300 shares $73,840.00 +8.3%N/A4.3 $56.80
4/15/20211,200 shares $69,360.00 +20.0%N/A3 $57.80
3/31/20211,000 shares $64,000.00 No ChangeN/A1.1 $64.00
3/15/20211,000 shares $58,000.00 -33.3%N/A0.9 $58.00
2/26/20211,500 shares $82,102.50 -16.7%N/A1.1 $54.74
2/12/20211,800 shares $107,946.00 -28.0%N/A1.2 $59.97
1/29/20212,500 shares $135,000.00 +56.3%N/A1.3 $54.00
1/15/20211,600 shares $86,400.00 No ChangeN/A0.7 $54.00

PureTech Health (NASDAQ:PRTC) Short Interest FAQ













PureTech Health (NASDAQ:PRTC) Short Interest Frequently Asked Questions

What is PureTech Health's current short interest?

Short interest is the volume of PureTech Health shares that have been sold short but have not yet been covered or closed out. As of September 30th, investors have sold 7,800 shares of PRTC short. Learn More on PureTech Health's current short interest.

What is a good short interest ratio for PureTech Health?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. PureTech Health currently has a short interest ratio of 2.0. Learn More on a good short interest ratio for PureTech Health

Is PureTech Health's short interest increasing or decreasing?

PureTech Health saw a increase in short interest in September. As of September 30th, there was short interest totaling 7,800 shares, an increase of 7,700.0% from the previous total of 100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does PureTech Health's short interest compare to its competitors?

0.00% of PureTech Health's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to PureTech Health: Ultragenyx Pharmaceutical Inc. (6.38%), I-Mab (0.00%), Alkermes plc (6.77%), TG Therapeutics, Inc. (10.23%), 23andMe Holding Co. (13.90%), Ionis Pharmaceuticals, Inc. (4.76%), Arvinas, Inc. (5.79%), Karuna Therapeutics, Inc. (7.97%), Aurinia Pharmaceuticals Inc. (17.28%), and Schrödinger, Inc. (8.29%).

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: S&P Global Inc. ($7.35 billion), Advanced Micro Devices, Inc. ($6.43 billion), Charter Communications, Inc. ($5.68 billion), Wayfair Inc. ($4.48 billion), Uber Technologies, Inc. ($3.77 billion), Canadian Pacific Railway Limited ($3.73 billion), Palo Alto Networks, Inc. ($3.10 billion), Zoom Video Communications, Inc. ($2.87 billion), Match Group, Inc. ($2.83 billion), and DoorDash, Inc. ($2.54 billion). View all of the most shorted stocks.

What does it mean to sell short PureTech Health stock?

Short selling PRTC is an investing strategy that aims to generate trading profit from PureTech Health as its price is falling. PureTech Health's stock is trading down $3.40 today. To short PureTech Health stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that PureTech Health will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against PureTech Health?

A short squeeze for PureTech Health occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of PRTC, which in turn drives the price of the stock up even further.

How often is PureTech Health's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PRTC, twice per month. The most recent reporting period available is September, 30 2021.



This page was last updated on 10/25/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.